Patent · US Expired

Piperazine and homopiperazine derivatives, pharmaceutical compositions containing them and process for preparing same

US5380724A · kind A · utility

15Cited by
5References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 16, 1993
Grant dateJan 10, 1995
Priority date
Expiry dateJun 16, 2013

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02P20/55
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention relates to novel compounds of the general formula (I) and the pharmaceutically acceptable acid addition salts thereof. In the general formula (I) ##STR1## wherein Lip, A.sup.1, A.sup.2, Het and n are defined as in the specification. The compounds of the general formula (I) inhibit the lipid peroxidation and therefore, they are useful for the treatment or prevention of diseases and conditions wherein the inhibition of lipid peroxidation is desirable.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.